DAVITA INC. Depreciation and Amortization
DAVITA INC. (DVA) reported Depreciation and Amortization of $708.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-02-11
- DAVITA INC. depreciation, depletion and amortization for the quarter ending 2014-12-31 was -$9.37M.
- DAVITA INC. depreciation, depletion and amortization for the quarter ending 2014-09-30 was $149.20M, a 12.38% increase year-over-year.
- DAVITA INC. depreciation, depletion and amortization for the quarter ending 2013-12-31 was -$16.16M.
- DAVITA INC. depreciation, depletion and amortization for the quarter ending 2013-09-30 was $132.76M.
- DAVITA INC. depreciation, depletion and amortization for fiscal 2025 was $708.25M, a 1.14% decline from fiscal 2024.
- DAVITA INC. depreciation, depletion and amortization for fiscal 2024 was $716.40M, a 2.73% decline from fiscal 2023.
- DAVITA INC. depreciation, depletion and amortization for fiscal 2023 was $736.47M, a 2.13% increase from fiscal 2022.
- DAVITA INC. depreciation, depletion and amortization for fiscal 2022 was $721.13M, a 7.99% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month | Depreciation, Depletion and Amortization 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $708.25M 10-K · filed 2026-02-11 | ||||
| 2024-12-31 | $716.40M 10-K · filed 2026-02-11 | ||||
| 2023-12-31 | $736.47M 10-K · filed 2026-02-11 | ||||
| 2022-12-31 | $721.13M 10-K · filed 2025-02-13 | ||||
| 2021-12-31 | $667.75M 10-K · filed 2024-02-14 | ||||
| 2020-12-31 | $616.63M 10-K · filed 2023-02-22 | ||||
| 2019-12-31 | $600.90M 10-K · filed 2022-02-11 | ||||
| 2018-12-31 | $574.80M 10-K · filed 2021-02-12 | ||||
| 2017-12-31 | $544.13M 10-K · filed 2020-02-21 | ||||
| 2016-12-31 | $494.94M 10-K · filed 2019-02-22 | $545.73M 10-K · filed 2017-02-24 | |||
| 2015-12-31 | $444.72M 10-K · filed 2018-02-23 | $475.48M 10-K · filed 2016-02-26 | |||
| 2014-12-31 | -$9.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $139.82M derived: sum of 2 quarters · filed 2017-02-24 | $428.31M 10-K · filed 2017-02-24 | ||
| 2014-09-30 | $149.20M 10-Q · filed 2014-11-06 | $437.68M 10-Q · filed 2014-11-06 | |||
| 2013-12-31 | -$16.16M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $116.61M derived: sum of 2 quarters · filed 2016-02-26 | $373.11M 10-K · filed 2016-02-26 | ||
| 2013-09-30 | $132.76M 10-Q · filed 2014-11-06 | $389.26M 10-Q · filed 2014-11-06 | |||
| 2012-12-31 | $299.81M 10-K · filed 2015-02-26 | ||||
| 2011-12-31 | $53.64M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $247.97M 10-K · filed 2014-02-21 | $249.06M 10-K · filed 2012-02-24 | ||
| 2011-09-30 | $194.33M 10-Q · filed 2011-11-04 | ||||
| 2010-12-31 | $43.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $217.79M 10-K · filed 2013-03-01 | $219.31M 10-K · filed 2011-02-25 | ||
| 2010-09-30 | $174.31M 10-Q · filed 2011-11-04 | ||||
| 2009-12-31 | $213.66M 8-K · filed 2012-07-06 | $214.51M 10-K · filed 2011-02-25 | |||
| 2008-12-31 | $201.01M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |